The increase in renin–angiotensin–aldosterone system (RAAS) activity has a pivotal role in the development of renovascular hypertension (Leenen et al., 1975; Lincevicius et al., 2015; Textor, 2017; Roncari et al., 2018). The gene discussed is REN; the disease is renovascular hypertension.